top of page


THE FUTURE OF ENGINEERED TISSUE

"Frontier Bio is paving the way for a future where organ donors are no longer needed, and animal testing is a thing of the past."
George Church
Scientific Advisor
TOWARDS ON-DEMAND HUMAN TISSUES
Only 10%
of Global Organ
Demand is Met
According to the World Health Organization
>150,000
Organ Transplants
Every Year
Lifetime costs for an organ transplant can exceed $1M

STARTING AT THE FOUNDATION:
BLOOD VESSELS
Engineering a new organ is impossible without its vascular system... blood vessels are the key. We are creating tissue-engineered blood vessels for use as vascular grafts to treat cardiovascular disease and trauma.
Cardiovascular disease is the #1 cause of death worldwide

Cardiovascular disease is the #1 cause of death worldwide
Synthetic Vessels Fail Too Often
The $2B synthetic vascular graft market is plagued by high failure rates, while autologous vessel harvesting is invasive, limited, and adds hours to critical surgeries.
Our Solution: A Living Vascular Graft
Our solution is a bioresorbable scaffold seeded at the bedside with the patient's own stem cells. The body remodels this "living graft" into a new, natural blood vessel, eliminating immune rejection and long manufacturing delays.
ESTABLISHING OURSELVES AS A LEADER IN TISSUE ENGINEERING
To build the future, we first had to master the present. We have successfully commercialized our human-based tissue models & tissue engineering services.

A More Relevant, Cruelty-Free Solution
Lab-grown human tissues provide more relevant insights and are a cruelty-free alternative compared to animal testing.



THE FUTURE IS HERE,
DON'T MISS IT
bottom of page

%2C%20white%20blue.png)



















